193 related articles for article (PubMed ID: 37288658)
1. Targeting myocardial equilibrative nucleoside transporter ENT1 provides cardioprotection by enhancing myeloid Adora2b signaling.
Ruan W; Li J; Choi S; Ma X; Liang Y; Nair R; Yuan X; Mills TW; Eltzschig HK
JCI Insight; 2023 Jun; 8(11):. PubMed ID: 37288658
[TBL] [Abstract][Full Text] [Related]
2. Equilibrative nucleoside transporter (ENT)-1-dependent elevation of extracellular adenosine protects the liver during ischemia and reperfusion.
Zimmerman MA; Tak E; Ehrentraut SF; Kaplan M; Giebler A; Weng T; Choi DS; Blackburn MR; Kam I; Eltzschig HK; Grenz A
Hepatology; 2013 Nov; 58(5):1766-78. PubMed ID: 23703920
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk between the equilibrative nucleoside transporter ENT2 and alveolar Adora2b adenosine receptors dampens acute lung injury.
Eckle T; Hughes K; Ehrentraut H; Brodsky KS; Rosenberger P; Choi DS; Ravid K; Weng T; Xia Y; Blackburn MR; Eltzschig HK
FASEB J; 2013 Aug; 27(8):3078-89. PubMed ID: 23603835
[TBL] [Abstract][Full Text] [Related]
4. Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice.
Grenz A; Bauerle JD; Dalton JH; Ridyard D; Badulak A; Tak E; McNamee EN; Clambey E; Moldovan R; Reyes G; Klawitter J; Ambler K; Magee K; Christians U; Brodsky KS; Ravid K; Choi DS; Wen J; Lukashev D; Blackburn MR; Osswald H; Coe IR; Nürnberg B; Haase VH; Xia Y; Sitkovsky M; Eltzschig HK
J Clin Invest; 2012 Feb; 122(2):693-710. PubMed ID: 22269324
[TBL] [Abstract][Full Text] [Related]
5. Coordination of ENT2-dependent adenosine transport and signaling dampens mucosal inflammation.
Aherne CM; Collins CB; Rapp CR; Olli KE; Perrenoud L; Jedlicka P; Bowser JL; Mills TW; Karmouty-Quintana H; Blackburn MR; Eltzschig HK
JCI Insight; 2018 Oct; 3(20):. PubMed ID: 30333323
[TBL] [Abstract][Full Text] [Related]
6. Differential Tissue-Specific Function of Adora2b in Cardioprotection.
Seo SW; Koeppen M; Bonney S; Gobel M; Thayer M; Harter PN; Ravid K; Eltzschig HK; Mittelbronn M; Walker L; Eckle T
J Immunol; 2015 Aug; 195(4):1732-43. PubMed ID: 26136425
[TBL] [Abstract][Full Text] [Related]
7. Equilibrative nucleoside transporter 1 plays an essential role in cardioprotection.
Rose JB; Naydenova Z; Bang A; Eguchi M; Sweeney G; Choi DS; Hammond JR; Coe IR
Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H771-7. PubMed ID: 20035027
[TBL] [Abstract][Full Text] [Related]
8. Enhancing Extracellular Adenosine Levels Restores Barrier Function in Acute Lung Injury Through Expression of Focal Adhesion Proteins.
Wang W; Chen NY; Ren D; Davies J; Philip K; Eltzschig HK; Blackburn MR; Akkanti B; Karmouty-Quintana H; Weng T
Front Mol Biosci; 2021; 8():636678. PubMed ID: 33778007
[No Abstract] [Full Text] [Related]
9. Hot shot induction and reperfusion with a specific blocker of the es-ENT1 nucleoside transporter before and after hypothermic cardioplegia abolishes myocardial stunning in acutely ischemic hearts despite metabolic derangement: hot shot drug delivery before hypothermic cardioplegia.
Abd-Elfattah AS; Tuchy GE; Jessen ME; Salter DR; Goldstein JP; Brunsting LA; Wechsler AS
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):961-970.e3. PubMed ID: 23422047
[TBL] [Abstract][Full Text] [Related]
10. Repression of the equilibrative nucleoside transporters dampens inflammatory lung injury.
Morote-Garcia JC; Köhler D; Roth JM; Mirakaj V; Eldh T; Eltzschig HK; Rosenberger P
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):296-305. PubMed ID: 23590299
[TBL] [Abstract][Full Text] [Related]
11. Absence of equilibrative nucleoside transporter 1 in ENT1 knockout mice leads to altered nucleoside levels following hypoxic challenge.
Rose JB; Naydenova Z; Bang A; Ramadan A; Klawitter J; Schram K; Sweeney G; Grenz A; Eltzschig H; Hammond J; Choi DS; Coe IR
Life Sci; 2011 Oct; 89(17-18):621-30. PubMed ID: 21872611
[TBL] [Abstract][Full Text] [Related]
12. Adora2b signaling on bone marrow derived cells dampens myocardial ischemia-reperfusion injury.
Koeppen M; Harter PN; Bonney S; Bonney M; Reithel S; Zachskorn C; Mittelbronn M; Eckle T
Anesthesiology; 2012 Jun; 116(6):1245-57. PubMed ID: 22531331
[TBL] [Abstract][Full Text] [Related]
13. Alveolar Epithelial A2B Adenosine Receptors in Pulmonary Protection during Acute Lung Injury.
Hoegl S; Brodsky KS; Blackburn MR; Karmouty-Quintana H; Zwissler B; Eltzschig HK
J Immunol; 2015 Aug; 195(4):1815-24. PubMed ID: 26188061
[TBL] [Abstract][Full Text] [Related]
14. Hypoxanthine uptake by skeletal muscle microvascular endothelial cells from equilibrative nucleoside transporter 1 (ENT1)-null mice: effect of oxidative stress.
Bone DB; Antic M; Quinonez D; Hammond JR
Microvasc Res; 2015 Mar; 98():16-22. PubMed ID: 25448155
[TBL] [Abstract][Full Text] [Related]
15. PMN-derived netrin-1 attenuates cardiac ischemia-reperfusion injury via myeloid ADORA2B signaling.
Li J; Conrad C; Mills TW; Berg NK; Kim B; Ruan W; Lee JW; Zhang X; Yuan X; Eltzschig HK
J Exp Med; 2021 Jun; 218(6):. PubMed ID: 33891683
[TBL] [Abstract][Full Text] [Related]
16. Blockade of equilibrative nucleoside transporter 1/2 protects against Pseudomonas aeruginosa-induced acute lung injury and NLRP3 inflammasome activation.
Chambers ED; White A; Vang A; Wang Z; Ayala A; Weng T; Blackburn M; Choudhary G; Rounds S; Lu Q
FASEB J; 2020 Jan; 34(1):1516-1531. PubMed ID: 31914698
[TBL] [Abstract][Full Text] [Related]
17. Signaling through hepatocellular A2B adenosine receptors dampens ischemia and reperfusion injury of the liver.
Zimmerman MA; Grenz A; Tak E; Kaplan M; Ridyard D; Brodsky KS; Mandell MS; Kam I; Eltzschig HK
Proc Natl Acad Sci U S A; 2013 Jul; 110(29):12012-7. PubMed ID: 23812746
[TBL] [Abstract][Full Text] [Related]
18. Predicting Drug Interactions with Human Equilibrative Nucleoside Transporters 1 and 2 Using Functional Knockout Cell Lines and Bayesian Modeling.
Miller SR; Zhang X; Hau RK; Jilek JL; Jennings EQ; Galligan JJ; Foil DH; Zorn KM; Ekins S; Wright SH; Cherrington NJ
Mol Pharmacol; 2021 Feb; 99(2):147-162. PubMed ID: 33262250
[TBL] [Abstract][Full Text] [Related]
19. Equilibrative Nucleoside Transporters 1 and 4: Which One Is a Better Target for Cardioprotection Against Ischemia-Reperfusion Injury?
Yang C; Leung GP
J Cardiovasc Pharmacol; 2015 Jun; 65(6):517-21. PubMed ID: 26070128
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human equilibrative nucleoside transporters by 4-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-6-imino-N-(naphthalen-2-yl)-1,3,5-triazin-2-amine.
Tang PCT; Yang C; Li RW; Lee SM; Hoi MP; Chan SW; Kwan YW; Tse CM; Leung GP
Eur J Pharmacol; 2016 Nov; 791():544-551. PubMed ID: 27388143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
